30 September 2016 - The EMA has published an EPAR for Sialanar (glycopyrronium bromide).
Sialanar was registered on 15 September 2016 for symptomatic treatment of severe sialorrhoea (chronic pathological drooling) in children and adolescents aged 3 years and older with chronic neurological disorders.